Shares of Absci Co. (NASDAQ:ABSI – Get Free Report) have received a consensus recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat.com reports.

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Absci Corporation before investing. In this article, we go over a few key ...

After hours: February 7 at 7:56:56 p.m. EST ...

After hours: 7:59:49 pm GMT-5 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: February 7 at 7:46:56 p.m. EST Loading Chart for ABCL ...